Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Targeted RNASeq using a custom panel of metabolic genes

ABSTRACT: Targeted RNASeq using a custom panel of metabolic genes

PROVIDER: PRJNA605015 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11031236.fastq.gz	Fastqsanger.gz
	SRR11031237.fastq.gz	Fastqsanger.gz
	SRR11031238.fastq.gz	Fastqsanger.gz
	SRR11031239.fastq.gz	Fastqsanger.gz
	SRR11031240.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

Targeted RNASeq using a custom panel of metabolic genes

Project description:Purpose: The purpose of this experiment was to determine the time point following activation at which greatest transcriptional differences in metabolic genes were observed between primary human CD4+ T cells treated with metformin + 2-deoxyglucose combination regimen and cells treated with vehicle. Methods: Targeted RNA-Seq data was generated from primary human CD4+ T cell mRNA using a Qiagen custom designed panel of metabolic genes and the Illumina TruSeq stranded mRNA prep. Results: We obtained differential gene expression between metformin + 2-deoxyglucose and vehicle-treated cells using the DESeq2 app in Illumina Basespace for a set of metabolic genes during different time points following activation, and found the greatest changes at 24hr.

2020-06-15 | GSE144352 | GEO

Human buffy coat gene expression, custom 250-plex Nanostring panel

Project description:Buffy coat PBMC RNA expression was tested using a custom Nanostring probe panel, to identify general immune and glucocorticoid receptor-associated immune genes. ClinicalTrials.gov Identifier: NCT00824941

2019-11-01 | GSE124549 | GEO

Custom Nanostring nCounter Pig (Sus scrofa) Cognitive Development Panel

Project description:Custom Nanostring nCounter Pig (Sus scrofa) Cognitive Development Panel

| PRJNA822401 | ENA

Targeted gene expression panel for meningiomas

Project description:A custom Nanostring nCounter panel of 100 or 75 meningioma related genes and reference genes was developed, and performed on human frozen and FFPE meningioma samples. This was done as part of a study developing and validating a targeted gene expression biomarker for meningioma outcomes after surgey and benefit from raditherapy.

2023-09-06 | GSE222054 | GEO

Human buffy coat gene expression, custom 250-plex Nanostring panel

Project description:Human buffy coat gene expression, custom 250-plex Nanostring panel

| PRJNA512473 | ENA

Molecular characterization of Georgia cohort of primary breast cancer FFPE tissues on custom breast cancer DASL panel

2009-10-23 | GSE18539 | GEO

Study to compare SET ER/PR index values from Affymetrix U133A microarrays to values from targeted RNASeq and to validate technical reproducibility on U133A microarrays

Project description:63 samples were profiled in replicates on Affymetrix microarrays and using a custom RNASeq panel. The samples were randomly split in a training and validation cohort. SET ER/PR was calculated and a linear model was trained and validated to reproduce values obtained by microarray using RNASeq. In addition, the microarray replicates were used to validate the technical reproducibility of SET ER/PR.

2019-05-30 | GSE129560 | GEO

custom mNGS

Project description:custom mNGS

| PRJEB42592 | ENA

Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma

Project description:Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma

| PRJNA790925 | ENA

Molecular characterization of Georgia cohort of primary breast cancer FFPE tissues on custom breast cancer DASL panel

Project description:Analysis of 143 formalin-fixed, paraffin-embedded (FFPE) primary breast tumors using a Custom Breast Cancer Panel and Human Cancer Panel for the DASL platform. Molecular markers between the pathology defined subtypes of breast cancer were assessed to hypothesize potential therapeutic targets specific to the subtypes Molecular Characterization of 143 primary breast carcinomas including 101 triple negative (TN: ER-, PR-, HER2-), 3 HER2-positive (HER2+: ER-, PR-, HER2+), and 39 hormone receptor-positive (HR+: ER+ and/or PR+)

2009-10-23 | E-GEOD-18539 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data